Sigilon Therapeutics Insider Trades

SGTX

Track insider trading activity from Sigilon Therapeutics executives and directors. See which insiders are buying and selling SGTX stock.

Trades Last 12 Months

SGTX Price

All Insider Trades for Sigilon Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ruffolo Robert R Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$84.4k 3,754 shares
$22.47
$22.47
Ashton Rickardt Philip CHIEF SCIENTIFIC OFFICER
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$199k 8,845 shares
$22.47
$22.47
Cole Douglas G. Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15.3k 683 shares
$22.47
$22.47
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$264k 11,730 shares
$22.47
$22.47
Cox John Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$38.4k 1,707 shares
$22.47
$22.47
Eli Lilly & Co 10% owner
Holding Value $2.25k 100 shares
Last Trade
Aug 11, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38.6M 1,718,493 shares
$22.47
$22.47
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$2.56M 113,960 shares
$22.47
$22.47
Kowalsky Matthew Paul CHIEF OF STAFF AND CLO
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$328k 14,615 shares
$22.47
$22.47
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$127k 5,639 shares
$22.47
$22.47
Vivaldi Coelho Rogerio PRESIDENT AND CEO
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.07M 47,551 shares
$22.47
$22.47
Patel Kavita Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$30.7k 1,366 shares
$22.47
$22.47
Pontes Josias CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$321k 14,271 shares
$22.47
$22.47
Shaff Eric D. Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$30.7k 1,366 shares
$22.47
$22.47
Story Brooke Director
Holding Value $200k 8,888 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15M 8,888 shares
$128.98
$22.47
Orfali May CHIEF MEDICAL OFFICER
Holding Value $225k 10,000 shares
Last Trade
Feb 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5M 10,000 shares
$250.12
$22.47
Holding Value $45.4M 2,022,222 shares
Last Trade
Jun 02, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$378M 200,000 shares
$1,889.42
$22.47
Smith Devyn CHIEF OPERATING OFFICER
Holding Value $2.13M 95,000 shares
Last Trade
Feb 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$639M 95,000 shares
$6,727.89
$22.47
Reicin Glenn CHIEF FINANCIAL OFFICER
Holding Value $1.24M 55,000 shares
Last Trade
Feb 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370M 55,000 shares
$6,727.89
$22.47
Corzo Deya CHIEF MEDICAL OFFICER
Holding Value $1.24M 55,000 shares
Last Trade
Feb 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370M 55,000 shares
$6,727.89
$22.47

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up